Spinal cord neuroplasticity following repeated opioid exposure and its relation to pathological pain

Annals of the New York Academy of Sciences

Volumn 933, Issue , 2001, Pages 175-184

  Mao, Jianren ^a   Mayer, David J ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; DEXTROMETHORPHAN; DIZOCILPINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE; MU OPIATE RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE; PROTEIN KINASE C;

ANALGESIA; ANIMAL MODEL; CHRONIC PAIN; CONFERENCE PAPER; DRUG DEPENDENCE; HYPERALGESIA; LONG TERM EXPOSURE; MULTIPLE CHEMICAL SENSITIVITY; NERVE CELL PLASTICITY; NEUROTOXICITY; NONHUMAN; PAIN; RAT; SPINAL CORD;

ANIMALIA;

EID: 0035033384     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb05823.x     Document Type: Conference Paper

References (44)

1. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801
2. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs
3. Delayed application of MK-801 attenuates development of morphine tolerance in rats
4. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat
5. The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat
6. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614
7. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy
8. MK 801 inhibits the development of morphine tolerance in the rat at spinal sites
9. Thermal hyperalgesia in association with the development of morphine tolerance in rats: Roles of excitatory amino acid receptors and protein kinase C
10. Antinociceptive tolerance to the mu-opioid agonist DAMGO is dose-dependently reduced by MK-801 in rats
11. Dextromethorphan attenuates and reverses analgesic tolerance to morphine
12. Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats
13. A protein kinase inhibitor, H-7, inhibits the development of tolerance to opioid antinociception
14. Influence of chronic morphine treatment on protein kinase C activity: Comparison with butorphanol and implication for opioid tolerance
15. The development of morphine tolerance and dependence is associated with translocation of protein kinase C
16. Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered mu-opioid receptor agonist in the mouse
17. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse
18. Pain-related increases in spinal cord membrane-bound protein kinase C following peripheral nerve injury
19. Spatial patterns of increased spinal cord membrane-bound protein kinase C and their relation to increases in 14C-2-deoxyglucose metabolic activity in rats with painful peripheral mononeuropathy
20. Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine
21. NMDA and opioid receptors: Their interactions in antinociception, tolerance, and neuroplasticity
22. Strychnine-enhanced transsynaptic degeneration of dorsal horn neurons in rats with an experimental painful peripheral neuropathy
23. Trans-synaptic degeneration in the superficial dorsal horn after sciatic nerve injury: Effects of a chronic constriction injury, transection, and strychnine
24. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions
25. The inhibition of nitric oxide-activated poly(ADP-ribose) synthetase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat
26. Neuronal plasticity and pain following peripheral tissue inflammation or nerve injury
27. Contribution of central neuroplasticity to pathological pain: Review of clinical and experimental evidence
28. MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy
29. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy
30. Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy
31. Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat
32. Nociceptive action of excitatory amino acids in the mouse: Effects of spinally administered opioids, phencyclidine, and sigma agonists
33. Central neural mediators of secondary hyperalgesia following heat injury in rats: Neuropeptides and excitatory amino acids
34. The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuli
35. Pretreatment with gangliosides reduces nociceptive responses associated with a rodent peripheral mononeuropathy
36. Post-injury treatment with GM1 ganglioside reduces nociceptive behaviors and spinal cord metabolic activity in rats with experimental peripheral mononeuropathy
37. Intrathecal GM1 ganglioside and local nerve anesthesia reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy
38. Increases in protein kinase C gamma immunoreactivity in the spinal cord dorsal horn of rats with painful peripheral mononeuropathy
39. Mechanisms of hyperalgesia and opiate tolerance: A current view of their possible interactions
40. Experimental mononeuropathy reduces the antinociceptive effects of morphine: Implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain
41. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive
42. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal and nerve-injured rats
43. Multiple chemical sensitivity: Potential role for neural sensitization
44. Neural sensitization model for multiple chemical sensitivity: Overview of theory and empirical evidence